Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-30 @ 12:40 PM
Study NCT ID:
NCT06004856
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICP-CL-00126
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None